TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • Sustainability
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > SMARTPHLEX > SMARTCHECK

SMARTCHECK

A smart tool for product information maintenance

SMARTCHECK uses artificial intelligence to compare the content of product information, such as summary of product characteristics (SmPC), package information leaflets (PIL) and packaging materials. The automated service enables the comparison of specific text according to the business rules and legislation in different countries.

Co-created with Accenture, PharmaLex has accomplished time savings of up to 65% and complete reduction in error risk.

Features

  • An intelligent system which supports the maintenance of medical product information e.g. packaging materials and patient information leaflets
  • Uses an 80% automated process to compare the content of recent outdated or country specific documents, identifies differences and proposes necessary amendments to bring them up to date
  • The tool is designed to work according to the defined business rules and customer specifications
  • Final decision making and approval remains human-based
  • Helps ensure that generic product are aligned to the innovator’s clinical information

Benefits

  • 47% reduction of workload in regulatory process for patient information leaflets (PILs)
  • 64% reduction of workload in regulatory process for Summary of Product Characteristics (SmPC)
  • 21% reduction of workload for regulatory process in Artwork (Outer and Box analysis)
  • 50% increase in productivity – 4 hours per active substance as opposed to 8 hours without automation

To find out more or request a demonstration

CONTACT US

Related News

Navigating New Digital Regulatory Requirements
Navigating New Digital Regulatory Requirements
7th February 2022
TGA Eases Timeline for Devices to Comply with Patient Information Requirements
TGA Eases Timeline for Devices to Comply with Patient Information Requirements
3rd November 2021
TGA repeals mandatory Conformity Assessment Certification and audit requirements
TGA repeals mandatory Conformity Assessment Certification and audit requirements
27th September 2021

Related Resources

Thought Leadership

  • Teknoscience publication: Successful marketing of medicinal cannabis
  • Improving the chances of EU approval
  • Latin America Leans Towards Greater Regulatory Harmonization
  • Spot the Difference
  • TOPRA // Regulatory Rapporteur Vol 15, No 10, October 2018

Fact Flyers

  • Strategic Regulatory Operations
  • Medical Device Regulations Transition Support
  • Medical Devices for the Pharmaceutical Industry
  • Advanced Therapies - Navigating through the Regulatory Framework
  • Regulatory Submissions for Tobacco and Vape Products
  • Regulatory Affairs Application Services
  • Regulatory Compliance

Case Studies

  • PharmaLex obtains rapid CE marking
  • PharmaLex applies EU regulatory affairs expertise
  • Pre-IND Meeting for an antibody-drug conjugate (ADC) for an advanced cancer indication
  • RIM-DMS Data Clean-up
  • Consultancy and eCTD submission support for master files
  • Portfolio Maintenance Outsourcing – Global RA responsibility
  • Strategic outsourcing of mature product portfolio
  • Global CMC responsibility during portfolio integration
  • End-2-end portfolio maintenance (outsourcing) program
  • Post–M&A PharmaLex program governance
  • Post–M&A pharma infrastructure development
  • Regulatory CMC compliance reduced workload by 20-25%
  • Regulatory publishing support on request
  • Strategy and delivery of global biosimilar development program

White Papers

  • Considerations When Applying for a Generic Medicine Authorisation
  • When your notified body is losing its designation under the medical device regulation
  • Top tips for a successful EU Orphan Drug Designation application
  • Tips for writing an outstanding Clinical Overview
  • The Medical Literature Monitoring of the EMA
  • Monitoring Compliance with Safety Exchange Agreements
  • Implementation of Eudravigilance Data Analysis System (EVDAS) in signal detection
  • QMS aspects of the Medical Device Regulation
  • Legal status switches in the UK
  • The medical device regulations and their implications on device vigilance
  • New responsibilities for importers
  • EU drug registration procedures
  • Successful marketing of medicinal cannabis and cannabis-derived products - Part II
  • Successful marketing of medicinal cannabis and cannabis-derived products
  • EU Clinical Trial Regulation
  • How will clinical trials be regulated after 1 January 2021?
  • In Vitro Diagnostic Medical Devices Regulation – Summary of changes and impact for manufacturers
  • Medical Device Software and Mobile Apps
  • Navigating the regulatory submission process for a class III medical device with ancillary medicine
  • The Medical Device Regulation – Readiness for May 2021

Webinars

  • SAP S/4HANA Validation: A Streamlined Approach
  • Get Your Design in Control
  • Medical Device Risk Management for Patient and Product Safety
  • TGA (Australia) Approaches for Accelerated Medicine Approvals
  • An Update to In Vitro Diagnostics Regulatory Requirements Worldwide
  • Medical Device Software: Current Developments in the Regulatory World
  • Emerging Markets: LATAM
  • Achieving and maintaining REG CMC Compliance
  • ISO IDMP Implementation in Europe

Related Services

  • ANDA Withdrawals
  • Digital Health Teaser Tool
  • MAA / NDA Submissions
  • MedTech Services
  • SMART MDR Teaser Tool
  • SMARTCHECK MDR
  • SMARTCHECK-MDR
  • SMARTDECISIONS
  • SMARTPHLEX
  • SMARTTRACE
  • Tobacco and Vape Products
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
pharmalexglobal PharmaLex @pharmalexglobal ·
15h

A Case Study in global End-to-End HQ #Outsourcing: ➡  Download the case study to discover more details: https://lnkd.in/ex_-jpxP

#pharmaindustry

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • Hard working and there when you need them

    Europe based large biotech
    Regulatory Manager
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for